Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Treatment Approaches for the Multiple Myeloma Patient in 2022"'
Publikováno v:
Hematology Am Soc Hematol Educ Program
The choice of treatment for patients with multiple myeloma (MM) at first relapse/progression is based on many factors: (1) treatment-related factors, which include the regimen used during first induction, the quality and duration of first response ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eae94b1297d7476e8a03343b88ea08b
https://doi.org/10.1182/hematology.2022000356
https://doi.org/10.1182/hematology.2022000356
Autor:
Caitlin L, Costello
Publikováno v:
Hematology Am Soc Hematol Educ Program
The development of new drugs and subsequent novel combinations for the treatment of newly diagnosed multiple myeloma (NDMM) has resulted in a plethora of treatment options that can make the choice of initial induction therapy a challenge. A greater u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::712992448eb5941f3a5753b5f25443d0
https://doi.org/10.1182/hematology.2022000404
https://doi.org/10.1182/hematology.2022000404
Publikováno v:
Hematology Am Soc Hematol Educ Program
Smoldering multiple myeloma (SMM) is an asymptomatic precursor condition to multiple myeloma (MM). The prevalence of SMM is 0.5% in persons over 40 years old; it is higher in men than women and increases with age. When SMM is diagnosed, a thorough di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d558f07382816bc3729fdac8c9bfade
https://europepmc.org/articles/PMC9821526/
https://europepmc.org/articles/PMC9821526/
